264 related articles for article (PubMed ID: 9422552)
1. Sociodemographic analysis of patients in radiation therapy oncology group clinical trials.
Chamberlain RM; Winter KA; Vijayakumar S; Porter AT; Roach M; Streeter O; Cox JD; Bondy ML
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):9-15. PubMed ID: 9422552
[TBL] [Abstract][Full Text] [Related]
2. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials.
Tejeda HA; Green SB; Trimble EL; Ford L; High JL; Ungerleider RS; Friedman MA; Brawley OW
J Natl Cancer Inst; 1996 Jun; 88(12):812-6. PubMed ID: 8637047
[TBL] [Abstract][Full Text] [Related]
3. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities.
Stewart JH; Bertoni AG; Staten JL; Levine EA; Gross CP
Ann Surg Oncol; 2007 Dec; 14(12):3328-34. PubMed ID: 17682824
[TBL] [Abstract][Full Text] [Related]
4. Cancer mortality in the United States by education level and race.
Albano JD; Ward E; Jemal A; Anderson R; Cokkinides VE; Murray T; Henley J; Liff J; Thun MJ
J Natl Cancer Inst; 2007 Sep; 99(18):1384-94. PubMed ID: 17848670
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer racial differences before age 40--implications for screening.
Johnson ET
J Natl Med Assoc; 2002 Mar; 94(3):149-56. PubMed ID: 11918384
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in the development of breast cancer metastases among older women: a multilevel study.
Schootman M; Jeffe DB; Gillanders WE; Aft R
Cancer; 2009 Feb; 115(4):731-40. PubMed ID: 19130463
[TBL] [Abstract][Full Text] [Related]
7. Residual treatment disparities after oncology referral for rectal cancer.
Morris AM; Billingsley KG; Hayanga AJ; Matthews B; Baldwin LM; Birkmeyer JD
J Natl Cancer Inst; 2008 May; 100(10):738-44. PubMed ID: 18477800
[TBL] [Abstract][Full Text] [Related]
8. Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008.
Cook MB; Rosenberg PS; McCarty FA; Wu M; King J; Eheman C; Anderson WF
Prostate; 2015 May; 75(7):758-63. PubMed ID: 25619191
[TBL] [Abstract][Full Text] [Related]
9. Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period.
Aizer AA; Wilhite TJ; Chen MH; Graham PL; Choueiri TK; Hoffman KE; Martin NE; Trinh QD; Hu JC; Nguyen PL
Cancer; 2014 May; 120(10):1532-9. PubMed ID: 24863392
[TBL] [Abstract][Full Text] [Related]
10. African American-white differences in lipids, lipoproteins, and apolipoproteins, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study.
Metcalf PA; Sharrett AR; Folsom AR; Duncan BB; Patsch W; Hutchinson RG; Szklo M; Davis CE; Tyroler HA
Am J Epidemiol; 1998 Oct; 148(8):750-60. PubMed ID: 9786230
[TBL] [Abstract][Full Text] [Related]
11. Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis.
Movsas B; Moughan J; Owen J; Coia LR; Zelefsky MJ; Hanks G; Wilson JF
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1145-50. PubMed ID: 17418963
[TBL] [Abstract][Full Text] [Related]
12. Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
Dess RT; Hartman HE; Mahal BA; Soni PD; Jackson WC; Cooperberg MR; Amling CL; Aronson WJ; Kane CJ; Terris MK; Zumsteg ZS; Butler S; Osborne JR; Morgan TM; Mehra R; Salami SS; Kishan AU; Wang C; Schaeffer EM; Roach M; Pisansky TM; Shipley WU; Freedland SJ; Sandler HM; Halabi S; Feng FY; Dignam JJ; Nguyen PL; Schipper MJ; Spratt DE
JAMA Oncol; 2019 Jul; 5(7):975-983. PubMed ID: 31120534
[TBL] [Abstract][Full Text] [Related]
13. Cartographic Mapping and Travel Burden to Assess and Develop Strategies to Improve Minority Access to National Cancer Clinical Trials.
Bruner DW; Pugh SL; Yeager KA; Bruner J; Curran W
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):702-9. PubMed ID: 26281827
[TBL] [Abstract][Full Text] [Related]
14. Minority Recruitment Trends in Phase III Prostate Cancer Clinical Trials (2003 to 2014): Progress and Critical Areas for Improvement.
Balakrishnan AS; Palmer NR; Fergus KB; Gaither TW; Baradaran N; Ndoye M; Breyer BN
J Urol; 2019 Feb; 201(2):259-267. PubMed ID: 30218761
[TBL] [Abstract][Full Text] [Related]
15. The impact of socioeconomic status and race on trial participation for older women with breast cancer.
Gross CP; Filardo G; Mayne ST; Krumholz HM
Cancer; 2005 Feb; 103(3):483-91. PubMed ID: 15597407
[TBL] [Abstract][Full Text] [Related]
16. The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies.
Mishkin G; Minasian LM; Kohn EC; Noone AM; Temkin SM
Gynecol Oncol; 2016 Dec; 143(3):611-616. PubMed ID: 27697287
[TBL] [Abstract][Full Text] [Related]
17. Regional and racial disparities in breast cancer-specific mortality.
Grann V; Troxel AB; Zojwalla N; Hershman D; Glied SA; Jacobson JS
Soc Sci Med; 2006 Jan; 62(2):337-47. PubMed ID: 16051406
[TBL] [Abstract][Full Text] [Related]
18. Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999.
Wu X; Chen VW; Martin J; Roffers S; Groves FD; Correa CN; Hamilton-Byrd E; Jemal A;
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1215-22. PubMed ID: 15247133
[TBL] [Abstract][Full Text] [Related]
19. Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001.
Kinsey T; Jemal A; Liff J; Ward E; Thun M
J Natl Cancer Inst; 2008 Jul; 100(14):1003-12. PubMed ID: 18612132
[TBL] [Abstract][Full Text] [Related]
20. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
Underwood W; Jackson J; Wei JT; Dunn R; Baker E; Demonner S; Wood DP
Cancer; 2005 Feb; 103(3):538-45. PubMed ID: 15612083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
